BioInformant

Your Global Leader in Stem Cell Market Research

Home » Cord Blood » Page 55

Cord Blood

Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.

Save the Cord Foundation and BioInformant Join Forces in Global Effort to Increase Cord Blood Banking Awareness

By Leave a Comment

PRESS RELEASE; April 1, 2015
WASHINGTON, DC, and TUCSON, AZ

Press release available at PR Web:  http://www.prweb.com/releases/2015/04/prweb12627399.htm.

For expectant parents, there are thousands of decisions to make in a short amount of time, including clothes, cribs, names, birthing methods, medical procedures, and more. It can be overwhelming, especially given the short-time frame involved. In addition to these decisions, there is an often overlooked decision: what to do with the extremely valuable stem and progenitor cells contained within the umbilical cord of the expected newborn? There are three options, which are to publicly donate, to privately store, or to discard the umbilical cord as medical waste. Two of those decisions require research and action on behalf of the parents, while the third is what happens when sufficient awareness and education has not been provided to allow parents to make an informed, educated decision. [Read more…]

MarketResearch.com: “Blockbuster” Year for Stem Cells Creates Market Opportunities

By Leave a Comment

PRESS RELEASE

WASHINGTON and NEW YORK CITY and LONDON, April 1, 2015 /PRNewswire/ — As a leading provider of market research reports and solutions, MarketResearch.com is pleased to highlight a report by BioInformant Worldwide, LLC, indicating that 2015 will be a year of market growth and opportunity for the stem cell industry.

For executives operating a stem cell company or cord blood bank, competing in the stem cell marketplace is a difficult task. You must analyze market conditions, predict industry trends, and act on market changes before the competition. [Read more…]

WideCells – Stem Cell Biotechnology and Regenerative Medicine in the 21st Century

By Leave a Comment

WideCells is a new and innovative stem cell technology and regenerative medicine company. It was founded by the CEO João Andrade and the CFO Lopes Gil. Dr Peter Hollands later joined as CSO bringing experience from other UK and international stem cell banks, clinical transplantation, teaching and research.

The first operations for WideCells were in Portugal, following on to the acquisition of the Spanish company Nacersalud to begin operations in Spain.

The continued success of operations in Portugal and Spain has led to the development of [Read more…]

Case Law & Legal Updates for the Cord Blood Banking Market

By Leave a Comment

Major Cord Blood Industry Change in 2015

Although we are only a few months into 2015, the cord blood banking market has already been experiencing rapid change.

The industry has seen structural advances occur, including a recent announcement of the Board of Directors for the Cord Blood Association, an  international nonprofit  that  promotes the  storage and use of cord blood and related tissues, such as cord tissue and placenta.

There have been major research advances as well. In one major example, a porcine animal study was conducted by the Mayo Clinic to evaluate the safety and feasibility of  cord blood-derived mononuclear cells (UBC-MNC) for use in promoting regeneration in pediatric congenital heart disease (CHD).

There have even been major clinical advances made already in 2015, with CryoSave leading and sponsoring a multicentre clinical trial following GCP-ICH standards, to determine if Cerebral Palsy can be addressed by infusing stem cells derived from umbilical cord blood and cord tissue into patients.

However, no understanding of the cord blood market is complete without a consideration of recent case law and significant legal decisions, which brings us to the focus on this market update.

Cord Blood Case Law & Legal Updates

Currently, there are three legal situations of which cord blood market participants should be aware: [Read more…]

Geographical Breakdown Of AABB Accredited Cord Blood Banks

By Leave a Comment

Within the United States, cord blood banks are subject to federal and state regulations and all cord blood banks must be registered with the U.S. FDA. The FDA governs all aspects of cord blood preservation, including the collection, processing, storage, labeling, packaging, and distribution of cord blood stem cells. In addition, there are a number of other agencies that accredit cord blood banks, including the AABB, Foundation for the Accreditation of Cellular Therapy (FACT), Clinical Laboratory Improvement Amendments (CLIA), and more.
[Read more…]

BioInformant's World-Class Clients